Andrea Local

650 total citations
17 papers, 406 citations indexed

About

Andrea Local is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Andrea Local has authored 17 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Hematology. Recurrent topics in Andrea Local's work include Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Andrea Local is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Andrea Local collaborates with scholars based in United States, Sweden and Germany. Andrea Local's co-authors include Kai Ge, Bing Ren, Chaochen Wang, William G. Rice, Stephen B. Howell, Wei Wang, Namit Singh, Dong Wang, Hui Huang and Huilin Zhou and has published in prestigious journals such as Nature Genetics, Blood and Cancer Research.

In The Last Decade

Andrea Local

17 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Local United States 6 344 38 28 28 25 17 406
Chi-Hung Nguyen France 14 471 1.4× 20 0.5× 54 1.9× 17 0.6× 16 0.6× 18 543
Shilpa Sampathi United States 9 342 1.0× 22 0.6× 51 1.8× 32 1.1× 14 0.6× 16 380
Taras Velychko Germany 11 316 0.9× 33 0.9× 25 0.9× 20 0.7× 18 0.7× 13 377
Lisa Molz United States 7 316 0.9× 23 0.6× 60 2.1× 15 0.5× 14 0.6× 9 374
Pekka Haapaniemi Finland 8 264 0.8× 41 1.1× 52 1.9× 49 1.8× 11 0.4× 11 339
Jung Shin Lee South Korea 10 522 1.5× 39 1.0× 50 1.8× 41 1.5× 40 1.6× 13 568
Samuel S. Oliver United States 9 515 1.5× 59 1.6× 41 1.5× 34 1.2× 50 2.0× 11 571
Sonja Ghidelli Germany 6 249 0.7× 35 0.9× 28 1.0× 12 0.4× 14 0.6× 6 300
Liana Oganesian United States 8 731 2.1× 40 1.1× 43 1.5× 42 1.5× 24 1.0× 8 788
Luisa Vigevani Spain 5 473 1.4× 12 0.3× 24 0.9× 36 1.3× 13 0.5× 5 532

Countries citing papers authored by Andrea Local

Since Specialization
Citations

This map shows the geographic impact of Andrea Local's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Local with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Local more than expected).

Fields of papers citing papers by Andrea Local

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Local. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Local. The network helps show where Andrea Local may publish in the future.

Co-authorship network of co-authors of Andrea Local

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Local. A scholar is included among the top collaborators of Andrea Local based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Local. Andrea Local is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tsai, Cheng‐Yu, Si Sun, Hongying Zhang, et al.. (2018). APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency. Molecular Cancer Therapeutics. 17(6). 1167–1176. 13 indexed citations
2.
Local, Andrea, Hongying Zhang, Khalid Benbatoul, et al.. (2018). APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells. Molecular Cancer Therapeutics. 17(6). 1177–1186. 68 indexed citations
3.
Yan, Jian, Shi-An A. Chen, Andrea Local, et al.. (2018). Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. Cell Research. 28(2). 204–220. 121 indexed citations
4.
Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2018). CG'806, a First-in-Class Pan-FLT3/Pan-BTK Inhibitor, Exhibits Broader and Greater Potency Than Ibrutinib Against Primary and Cultured Malignant B Cells. Blood. 132(Supplement 1). 3503–3503. 2 indexed citations
5.
Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2018). Abstract 794: CG'806, a first-in-class pan-FLT3/pan-BTK inhibitor, targets multiple pathways to kill diverse subtypes of acute myeloid leukemia and B-cell malignancy in vitro. Cancer Research. 78(13_Supplement). 794–794. 3 indexed citations
6.
Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2017). CG '806, a Highly Potent First-in-Class Pan-FLT3/BTK Inhibitor, Targets Multiple Clusters of Kinases Operative in Diverse Subtypes of Acute Myeloid Leukemia. Blood. 130. 5063–5063. 1 indexed citations
7.
8.
Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2017). CG '806, a First-in-Class Non-Covalent Pan-FLT3/BTK Inhibitor, Exerts Superior Potency Against B-Cell Malignant Cells. Blood. 130. 5200–5200. 2 indexed citations
9.
Local, Andrea, Hui Huang, Claudio P. Albuquerque, et al.. (2017). Identification of H3K4me1-associated proteins at mammalian enhancers. Nature Genetics. 50(1). 73–82. 151 indexed citations
10.
Kurtz, Stephen E., Beth Wilmot, Shannon K. McWeeney, et al.. (2017). Abstract 44: CG′806, a first-in-class FLT3/BTK inhibitor, exhibits potent activity against AML patient samples with mutant or wild type FLT3, as well as other hematologic malignancy subtypes. Clinical Cancer Research. 23(24_Supplement). 44–44. 1 indexed citations
11.
Zhang, Weiguo, Hongying Zhang, Andrea Local, et al.. (2017). Abstract 25: CG′806, a first-in-class FLT3/BTK inhibitor, exerts superior potency against AML cells harboring ITD, TKD and gatekeeper mutated FLT3 or wild-type FLT3. Clinical Cancer Research. 23(24_Supplement). 25–25. 1 indexed citations
12.
Zhang, Hongying, et al.. (2017). CG′806, a First-in-Class FLT3/BTK Inhibitor, Exerts Superior Potency against AML Cells Harboring ITD, TKD and Gatekeeper Mutated FLT3 or Wild-Type FLT3. Clinical Lymphoma Myeloma & Leukemia. 17. S274–S275. 3 indexed citations
13.
Upadhayaya, Ram Shankar, et al.. (2016). Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies. Blood. 128(22). 5212–5212. 1 indexed citations
14.
Zhang, Hongying, Andrea Local, Khalid Benbatoul, et al.. (2016). Inhibition of c-Myc By Apto-253 As an Innovative Therapeutic Approach to Induce Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia. Blood. 128(22). 1716–1716. 3 indexed citations
15.
Rice, William G., Jeff Lightfoot, Hongying Zhang, et al.. (2015). Clinical Pharmacokinetics of Apto-253 Support Its Use As a Novel Agent for the Treatment of Relapsed or Refractory Hematologic Malignancies. Blood. 126(23). 4934–4934. 1 indexed citations
16.
Local, Andrea, et al.. (1999). Identification and Expression of Cotton (Gossypium hirsutum L.) Plastidial Carbonic Anhydrase. Plant and Cell Physiology. 40(12). 1262–1270. 12 indexed citations
17.
Everall, Neil, John M. Chalmers, Andrea Local, & S. Allen. (1996). Measurement of surface orientation in uniaxial poly(ethylene terephthalate) films using polarised specular reflectance Fourier transform infrared microscopy. Vibrational Spectroscopy. 10(2). 253–259. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi-Hung Nguyen Breakdown of academic impact, for papers by Shilpa Sampathi Breakdown of academic impact, for papers by Taras Velychko Breakdown of academic impact, for papers by Lisa Molz Breakdown of academic impact, for papers by Pekka Haapaniemi Breakdown of academic impact, for papers by Jung Shin Lee Breakdown of academic impact, for papers by Samuel S. Oliver Breakdown of academic impact, for papers by Sonja Ghidelli Breakdown of academic impact, for papers by Liana Oganesian Breakdown of academic impact, for papers by Luisa Vigevani
Rankless by CCL
2026